- Wojciech Chrusciel is a managing director and president of the board with experience leading organizations in the pharmaceutical, insurance, and logistics industries in Poland.
- He has expertise in the Polish healthcare system and advised the Ministry of Health of the Republic of Poland.
- Chrusciel has extensive experience restructuring businesses and building and managing large teams.
Melanie Hans has over 25 years of experience working in administrative and secretarial roles in Germany and the UK. She is currently a legal secretary for Irwin Mitchell LLP in London, providing support to partners in corporate and employment law teams. Prior to this, she held secretarial positions at other law firms and companies in London, Frankfurt, and elsewhere in Germany. She has strong computer, organizational, and language skills and holds a Realschulabschluss secondary school qualification equivalent to 11 GCSEs from Martin-Buber-Schule in Groß-Gerau, Germany.
Dagmara Kunicka is seeking new opportunities in marketing. She has over 8 years of experience in marketing roles within the medical sector, most recently as Marketing Manager at PAUL HARTMANN Polska Sp. z o.o. where she was responsible for planning marketing strategies, product launches, market research and representing the company at medical conferences. She holds a Master's degree in Economics from Uniwersity of Lodz and is fluent in English.
Rudi Jansen is a business executive with over 25 years of experience in the pharmaceutical industry. He has held CEO positions in Europe and has extensive experience turning around businesses. He is seeking new executive positions and enjoys developing businesses, fundraising, and working with teams.
French-Swedish Executive Seminar On Value-Based Healthcare - A5Ebba G. Hult
This document provides an agenda and background information for a French-Swedish executive seminar on value-based healthcare taking place in Paris on June 13th, 2016. The seminar is being organized by Business Sweden and will bring together healthcare leaders and experts from France and Sweden. The agenda includes opening speeches from Swedish and French officials, panels on incentivizing improved health outcomes and efficiency, and improving outcomes through innovation and collaboration. Featured speakers will represent hospitals, government agencies, and life sciences companies from both countries. The goal of the seminar is to deepen partnership between France and Sweden in healthcare and find ways to jointly tackle health challenges through a value-based approach.
Jocelyn Marquis has over 15 years of experience in the pharmaceutical and medical industries. She has held scientific and strategic roles at companies such as Medzone, Xprtiz, AstraZeneca, Biovail Pharmaceuticals, XpO, and Actelion Pharmaceuticals. Her experience includes providing scientific and strategic consultation, project management, marketing, training, and continuing medical education. She has strong skills in building relationships, communicating scientific information, and identifying new business opportunities.
Urs H. Flueckiger has over 30 years of experience in senior management roles in the pharmaceutical industry. He has a Masters in Economics and has worked for Roche in various countries, including Switzerland, South Korea, the Philippines, and Saudi Arabia. His experience includes launching new drugs, managing country operations, and closing/divesting facilities. Currently he is the Chairman of TwentyTwelve AG, a fashion retail business in Basel.
Maarten Nibbelke is a MEDTECH executive with experience as a CEO and general manager. He has held senior roles at Baxter and helped grow revenues significantly as CEO of Polyganics. Currently he operates his own consulting business, 2MEDICAL-europe, and developed a medical device called ClearView Scopewarmer. He has over 25 years of experience in sales, marketing, operations and business development for medical devices and pharmaceutical companies.
Germany provides doctors from the EU free movement and the right to practice medicine. Doctors must have their qualifications recognized by the local medical council. Working in Germany offers stable employment in hospitals, with salaries and taxes deducted. The healthcare system is well-funded and high quality, though there is a shortage of specialized staff. Cultural and professional integration is supported through language, social, and community resources across Germany.
Melanie Hans has over 25 years of experience working in administrative and secretarial roles in Germany and the UK. She is currently a legal secretary for Irwin Mitchell LLP in London, providing support to partners in corporate and employment law teams. Prior to this, she held secretarial positions at other law firms and companies in London, Frankfurt, and elsewhere in Germany. She has strong computer, organizational, and language skills and holds a Realschulabschluss secondary school qualification equivalent to 11 GCSEs from Martin-Buber-Schule in Groß-Gerau, Germany.
Dagmara Kunicka is seeking new opportunities in marketing. She has over 8 years of experience in marketing roles within the medical sector, most recently as Marketing Manager at PAUL HARTMANN Polska Sp. z o.o. where she was responsible for planning marketing strategies, product launches, market research and representing the company at medical conferences. She holds a Master's degree in Economics from Uniwersity of Lodz and is fluent in English.
Rudi Jansen is a business executive with over 25 years of experience in the pharmaceutical industry. He has held CEO positions in Europe and has extensive experience turning around businesses. He is seeking new executive positions and enjoys developing businesses, fundraising, and working with teams.
French-Swedish Executive Seminar On Value-Based Healthcare - A5Ebba G. Hult
This document provides an agenda and background information for a French-Swedish executive seminar on value-based healthcare taking place in Paris on June 13th, 2016. The seminar is being organized by Business Sweden and will bring together healthcare leaders and experts from France and Sweden. The agenda includes opening speeches from Swedish and French officials, panels on incentivizing improved health outcomes and efficiency, and improving outcomes through innovation and collaboration. Featured speakers will represent hospitals, government agencies, and life sciences companies from both countries. The goal of the seminar is to deepen partnership between France and Sweden in healthcare and find ways to jointly tackle health challenges through a value-based approach.
Jocelyn Marquis has over 15 years of experience in the pharmaceutical and medical industries. She has held scientific and strategic roles at companies such as Medzone, Xprtiz, AstraZeneca, Biovail Pharmaceuticals, XpO, and Actelion Pharmaceuticals. Her experience includes providing scientific and strategic consultation, project management, marketing, training, and continuing medical education. She has strong skills in building relationships, communicating scientific information, and identifying new business opportunities.
Urs H. Flueckiger has over 30 years of experience in senior management roles in the pharmaceutical industry. He has a Masters in Economics and has worked for Roche in various countries, including Switzerland, South Korea, the Philippines, and Saudi Arabia. His experience includes launching new drugs, managing country operations, and closing/divesting facilities. Currently he is the Chairman of TwentyTwelve AG, a fashion retail business in Basel.
Maarten Nibbelke is a MEDTECH executive with experience as a CEO and general manager. He has held senior roles at Baxter and helped grow revenues significantly as CEO of Polyganics. Currently he operates his own consulting business, 2MEDICAL-europe, and developed a medical device called ClearView Scopewarmer. He has over 25 years of experience in sales, marketing, operations and business development for medical devices and pharmaceutical companies.
Germany provides doctors from the EU free movement and the right to practice medicine. Doctors must have their qualifications recognized by the local medical council. Working in Germany offers stable employment in hospitals, with salaries and taxes deducted. The healthcare system is well-funded and high quality, though there is a shortage of specialized staff. Cultural and professional integration is supported through language, social, and community resources across Germany.
FASS - Presentation and discussion of Good Practice Example: MaliniakNowgen
"FASS - Presentation and discussion of Good Practice Example", presented by Ann Maliniak, Swedish Association of the Pharmaceutical Industry (LIF), Sweden, at EUPATI 2014 Workshop on 2 April 2014 in Warsaw
Slobodanka Kostic is a senior scientist and formulation expert in Bosnia and Herzegovina with over 15 years of experience in pharmaceutical research and development. She has extensive experience developing solid oral dosage forms and managing projects from initial feasibility studies through commercial manufacturing. Currently she works at Bosnalijek developing new drug formulations and leading projects involving preclinical testing, scale-up studies, and regulatory submissions. She has a degree in pharmaceutical engineering and additional training in areas such as good clinical practice, tablet production, and pharmaceutical coating technologies.
This document provides information to help Europeans citizens move and work in Germany. It discusses the right to free movement within the EU and recognition of professional qualifications between member states. It then provides an overview of Germany, including key facts, politics, the economy, healthcare system, salaries, and the process for foreign doctors to work there. Additional sections cover typical work responsibilities, quality management, language, culture and living, and a map showing Germany's location in Europe.
Market Access, Pricing and Reimbursement streamlinedWang-yee Liu
This document provides an agenda for the "Market Access, Pricing and Reimbursement 2016 Europe" conference taking place on June 9-10, 2016 in London. The agenda includes presentations and speakers on topics related to market access strategies, challenges in pharmaceutical pricing and reimbursement, and maximizing access in emerging markets. Key industry experts scheduled to speak include leaders from pharmaceutical companies such as Celgene, Sanofi, Alcon, and Daiichi Sankyo. The conference aims to provide a platform for stakeholders to discuss macroeconomic factors, policies, and drivers influencing the pharmaceutical industry.
Changing times ask for solid relationships.
Times are changing. A renewed interest from big pharma in the rare disease landscape
has awakened due to large-scale patent expirations, competition from generics &
biosimilars, anemic pipelines, escalating clinical trial costs and a global health-care
reform. This means that the traditional blockbuster model has become less viable while
the revenue-generating potential of orphan drugs has shown to be huge with a greater
return on investment than non-orphan drugs. According to EvaluatePharma, the orphan
drugs sales will grow at an annual rate of 11% and constitute 19% of the total share of
prescription drugs by 2020, totalling 176 billion dollars.
The rare disease landscape is very complex due to the large amount of stakeholders
involved. Despite their different interests they have one goal in common: getting an
orphan drug approval that will help save or improve lives. But there are many challenges
on the road to orphan drug designation:
• Complex and changing national and regional regulations
• Clinical trial design and finding & keeping patients
• The lack of a central database designed specifically to list patient registries, which
asks for close stakeholder engagement
• Partnering and establishing financing for future development
• Establishing a foundation for price that is balanced and sustainable
• Achieving an efficient and timely access to market with equal access for patients
around the world
• Achieving timely and correct diagnosis to enable higher quality of life and more time
and information for developers
More information: http://www.orphandrugssummit.com/
WE Patients Foundation - Presentation of the team and activitiesFundacja MY PACJENCI
The WE Patients Foundation was created in 2012 in Poland to support patient participation in healthcare decision making and provide support to patient organizations. The Foundation implements various projects focused on health education, health promotion, and building cooperation between stakeholders in the healthcare system. It has a team of experts in areas like healthcare policy, communication, and law. The Foundation partners with other organizations and experts to conduct research, analysis, and educational initiatives to empower patients.
- Dr. Dusan Longinovic is a physician specialized in health economics, organization, and pricing systems with over 20 years of experience in public health, pharmaceutical industry, and private healthcare.
- He currently serves as the CEO of his own healthcare consulting firm, Signature SANTE, where he advises public and private hospitals on improving financial performance and negotiating with health authorities.
- Prior to this, he held several leadership roles at Sanofi and Generale de Sante, where he implemented clinical information and activity-based payment systems across Europe.
This document discusses innovation at Teva Pharmaceutical Works in Hungary. It provides background on Teva, a global pharmaceutical company, and its acquisition and development of Biogal Pharmaceutical Works in Hungary. Over time, Biogal was integrated into Teva's network and renamed Teva Pharmaceutical Works, with production sites in Debrecen, Godollo, and Sajobábony. Teva Pharmaceutical Works engages in research and development, manufacturing of drugs and active pharmaceutical ingredients, and has collaborations with Hungarian universities.
The Swecare Foundation brings Swedish medical expertise and technology to healthcare facilities around the world. It was founded in 1978 to promote growth, international competitiveness, and exports for Sweden's life science sector and healthcare. Swecare is a unique independent platform for multidisciplinary cooperation between public sector organizations, hospitals, universities, and medical companies to develop international business. It has a network of approximately 300 member organizations and assists them with export promotion, foreign visits to Sweden, and locating cooperation partners in other countries.
Mostafa Abd Almageed Albadawy is seeking a challenging position in sales and marketing. He has a Bachelor's degree in pharmaceutical sciences from Al-Azhar University in Egypt. He has over 5 years of work experience in pharmaceutical sales, most recently working from 2014 to 2016 as a Medical Representative for Hikma Pharmaceuticals in Saudi Arabia. He is married, holds a valid Saudi driving license and Iqama, and his nationality is Egyptian.
The Federal Agency for Medicines and Health Products (FAMHP) is the competent authority responsible for the quality, safety and efficacy of medicines and health products in Belgium. It ensures medicines and health products are authorized and used properly from development through post-marketing. Key activities include clinical trial authorization, marketing authorization, production inspections, pharmacovigilance, and ensuring proper use. Applicants can request scientific-technical advice from FAMHP to facilitate drug development and availability of innovative treatments for patients. Advice requests require supporting documentation and a fee and are reviewed within defined timelines depending on type.
Gogo Acevski has over 6 years of experience as a Medical Sales Representative for Actavis Pharmaceuticals in Macedonia. He holds a Master's degree in Pharmacy from the Faculty of Pharmacy in Skopje. His responsibilities included developing marketing strategies, promoting pharmaceutical products to physicians and pharmacists, and managing commercial activities with pharmacies. He has strong computer and foreign language skills and has participated in numerous trainings to continuously improve his skills in areas like communication, sales, and team management.
Ahmed EltiganyMohammed is a senior medical representative at Medical Union Pharmaceuticals in Egypt with over 13 years of experience in sales and marketing of pharmaceutical products. He holds a Bachelor's degree in Veterinary Medicine and seeks a position as District Manager or Medical Sales Supervisor to utilize his expertise in achieving sales targets, growing market share, and contributing to company success. His resume details his educational background and training, work history demonstrating sales achievements at multiple pharmaceutical companies, languages, skills, and references.
Mohammad Thabit is seeking a position that allows him to utilize his 10 years of experience in pharmaceutical sales, marketing, and medical education. He has an MBA in marketing and project management. His experience includes managing medical departments, developing educational programs, conducting medical research projects, and publishing medical journals in Egypt. He also has several years of experience as a senior medical representative in Saudi Arabia, achieving sales targets. Thabit is a skilled communicator and project leader seeking an opportunity for growth with a progressive company.
Dr. Anita Wydoodt is an experienced healthcare leader in the Netherlands and Belgium with over 25 years of experience. She currently holds several board and supervisory positions, including at Meander Medisch Centrum, Koninklijke Kentalis, and Omring. Her experience includes strategic leadership roles at hospitals and healthcare organizations, focusing on quality improvement, safety, education, and innovation. She strives to improve patient care through collaborative dialogue and a balanced approach to quality and efficiency.
Eslam Elsayed Mohammed is seeking a job as a medical representative. He has a bachelor's degree in pharmacy from Helwan University and experience as a community pharmacist and medical representative at GSK Egypt and Ibn Sina Pharmacy in Oman. He has excellent English skills and has received exceptional degrees in respiratory disease training courses from GSK.
Anderson Huang has over 15 years of experience in pharmaceutical marketing. He is currently the Marketing Manager for Roche Pharma Taiwan focusing on the HER2 franchise. Previously he held various marketing roles at Novartis Pharma Taiwan and Basel focusing on oncology, immunology, and transplant portfolios. He has a strong track record of successfully launching new products and driving growth for mature brands.
Beximco Pharmaceuticals Ltd. is a leading Bangladeshi pharmaceutical company established in 1976. It has over 2,500 employees and manufacturing facilities certified by global regulatory bodies. Beximco Pharma produces over 400 products across various therapeutic categories and is the largest exporter of pharmaceuticals in Bangladesh. The company has a growing global presence across five continents and is the only Bangladeshi pharmaceutical company marketing products in the US.
IMPREX provides marketing and communications services to the medical and pharmaceutical industries, including the creation of promotional materials such as brochures, posters, and patient education materials. Headed by Onkarjot Bhatia Bakhshi, who has a background in biochemistry and marketing experience in the pharmaceutical industry, IMPREX recognizes that the healthcare industry is shifting towards empowered consumers and the important role social media now plays in promotion.
FASS - Presentation and discussion of Good Practice Example: MaliniakNowgen
"FASS - Presentation and discussion of Good Practice Example", presented by Ann Maliniak, Swedish Association of the Pharmaceutical Industry (LIF), Sweden, at EUPATI 2014 Workshop on 2 April 2014 in Warsaw
Slobodanka Kostic is a senior scientist and formulation expert in Bosnia and Herzegovina with over 15 years of experience in pharmaceutical research and development. She has extensive experience developing solid oral dosage forms and managing projects from initial feasibility studies through commercial manufacturing. Currently she works at Bosnalijek developing new drug formulations and leading projects involving preclinical testing, scale-up studies, and regulatory submissions. She has a degree in pharmaceutical engineering and additional training in areas such as good clinical practice, tablet production, and pharmaceutical coating technologies.
This document provides information to help Europeans citizens move and work in Germany. It discusses the right to free movement within the EU and recognition of professional qualifications between member states. It then provides an overview of Germany, including key facts, politics, the economy, healthcare system, salaries, and the process for foreign doctors to work there. Additional sections cover typical work responsibilities, quality management, language, culture and living, and a map showing Germany's location in Europe.
Market Access, Pricing and Reimbursement streamlinedWang-yee Liu
This document provides an agenda for the "Market Access, Pricing and Reimbursement 2016 Europe" conference taking place on June 9-10, 2016 in London. The agenda includes presentations and speakers on topics related to market access strategies, challenges in pharmaceutical pricing and reimbursement, and maximizing access in emerging markets. Key industry experts scheduled to speak include leaders from pharmaceutical companies such as Celgene, Sanofi, Alcon, and Daiichi Sankyo. The conference aims to provide a platform for stakeholders to discuss macroeconomic factors, policies, and drivers influencing the pharmaceutical industry.
Changing times ask for solid relationships.
Times are changing. A renewed interest from big pharma in the rare disease landscape
has awakened due to large-scale patent expirations, competition from generics &
biosimilars, anemic pipelines, escalating clinical trial costs and a global health-care
reform. This means that the traditional blockbuster model has become less viable while
the revenue-generating potential of orphan drugs has shown to be huge with a greater
return on investment than non-orphan drugs. According to EvaluatePharma, the orphan
drugs sales will grow at an annual rate of 11% and constitute 19% of the total share of
prescription drugs by 2020, totalling 176 billion dollars.
The rare disease landscape is very complex due to the large amount of stakeholders
involved. Despite their different interests they have one goal in common: getting an
orphan drug approval that will help save or improve lives. But there are many challenges
on the road to orphan drug designation:
• Complex and changing national and regional regulations
• Clinical trial design and finding & keeping patients
• The lack of a central database designed specifically to list patient registries, which
asks for close stakeholder engagement
• Partnering and establishing financing for future development
• Establishing a foundation for price that is balanced and sustainable
• Achieving an efficient and timely access to market with equal access for patients
around the world
• Achieving timely and correct diagnosis to enable higher quality of life and more time
and information for developers
More information: http://www.orphandrugssummit.com/
WE Patients Foundation - Presentation of the team and activitiesFundacja MY PACJENCI
The WE Patients Foundation was created in 2012 in Poland to support patient participation in healthcare decision making and provide support to patient organizations. The Foundation implements various projects focused on health education, health promotion, and building cooperation between stakeholders in the healthcare system. It has a team of experts in areas like healthcare policy, communication, and law. The Foundation partners with other organizations and experts to conduct research, analysis, and educational initiatives to empower patients.
- Dr. Dusan Longinovic is a physician specialized in health economics, organization, and pricing systems with over 20 years of experience in public health, pharmaceutical industry, and private healthcare.
- He currently serves as the CEO of his own healthcare consulting firm, Signature SANTE, where he advises public and private hospitals on improving financial performance and negotiating with health authorities.
- Prior to this, he held several leadership roles at Sanofi and Generale de Sante, where he implemented clinical information and activity-based payment systems across Europe.
This document discusses innovation at Teva Pharmaceutical Works in Hungary. It provides background on Teva, a global pharmaceutical company, and its acquisition and development of Biogal Pharmaceutical Works in Hungary. Over time, Biogal was integrated into Teva's network and renamed Teva Pharmaceutical Works, with production sites in Debrecen, Godollo, and Sajobábony. Teva Pharmaceutical Works engages in research and development, manufacturing of drugs and active pharmaceutical ingredients, and has collaborations with Hungarian universities.
The Swecare Foundation brings Swedish medical expertise and technology to healthcare facilities around the world. It was founded in 1978 to promote growth, international competitiveness, and exports for Sweden's life science sector and healthcare. Swecare is a unique independent platform for multidisciplinary cooperation between public sector organizations, hospitals, universities, and medical companies to develop international business. It has a network of approximately 300 member organizations and assists them with export promotion, foreign visits to Sweden, and locating cooperation partners in other countries.
Mostafa Abd Almageed Albadawy is seeking a challenging position in sales and marketing. He has a Bachelor's degree in pharmaceutical sciences from Al-Azhar University in Egypt. He has over 5 years of work experience in pharmaceutical sales, most recently working from 2014 to 2016 as a Medical Representative for Hikma Pharmaceuticals in Saudi Arabia. He is married, holds a valid Saudi driving license and Iqama, and his nationality is Egyptian.
The Federal Agency for Medicines and Health Products (FAMHP) is the competent authority responsible for the quality, safety and efficacy of medicines and health products in Belgium. It ensures medicines and health products are authorized and used properly from development through post-marketing. Key activities include clinical trial authorization, marketing authorization, production inspections, pharmacovigilance, and ensuring proper use. Applicants can request scientific-technical advice from FAMHP to facilitate drug development and availability of innovative treatments for patients. Advice requests require supporting documentation and a fee and are reviewed within defined timelines depending on type.
Gogo Acevski has over 6 years of experience as a Medical Sales Representative for Actavis Pharmaceuticals in Macedonia. He holds a Master's degree in Pharmacy from the Faculty of Pharmacy in Skopje. His responsibilities included developing marketing strategies, promoting pharmaceutical products to physicians and pharmacists, and managing commercial activities with pharmacies. He has strong computer and foreign language skills and has participated in numerous trainings to continuously improve his skills in areas like communication, sales, and team management.
Ahmed EltiganyMohammed is a senior medical representative at Medical Union Pharmaceuticals in Egypt with over 13 years of experience in sales and marketing of pharmaceutical products. He holds a Bachelor's degree in Veterinary Medicine and seeks a position as District Manager or Medical Sales Supervisor to utilize his expertise in achieving sales targets, growing market share, and contributing to company success. His resume details his educational background and training, work history demonstrating sales achievements at multiple pharmaceutical companies, languages, skills, and references.
Mohammad Thabit is seeking a position that allows him to utilize his 10 years of experience in pharmaceutical sales, marketing, and medical education. He has an MBA in marketing and project management. His experience includes managing medical departments, developing educational programs, conducting medical research projects, and publishing medical journals in Egypt. He also has several years of experience as a senior medical representative in Saudi Arabia, achieving sales targets. Thabit is a skilled communicator and project leader seeking an opportunity for growth with a progressive company.
Dr. Anita Wydoodt is an experienced healthcare leader in the Netherlands and Belgium with over 25 years of experience. She currently holds several board and supervisory positions, including at Meander Medisch Centrum, Koninklijke Kentalis, and Omring. Her experience includes strategic leadership roles at hospitals and healthcare organizations, focusing on quality improvement, safety, education, and innovation. She strives to improve patient care through collaborative dialogue and a balanced approach to quality and efficiency.
Eslam Elsayed Mohammed is seeking a job as a medical representative. He has a bachelor's degree in pharmacy from Helwan University and experience as a community pharmacist and medical representative at GSK Egypt and Ibn Sina Pharmacy in Oman. He has excellent English skills and has received exceptional degrees in respiratory disease training courses from GSK.
Anderson Huang has over 15 years of experience in pharmaceutical marketing. He is currently the Marketing Manager for Roche Pharma Taiwan focusing on the HER2 franchise. Previously he held various marketing roles at Novartis Pharma Taiwan and Basel focusing on oncology, immunology, and transplant portfolios. He has a strong track record of successfully launching new products and driving growth for mature brands.
Beximco Pharmaceuticals Ltd. is a leading Bangladeshi pharmaceutical company established in 1976. It has over 2,500 employees and manufacturing facilities certified by global regulatory bodies. Beximco Pharma produces over 400 products across various therapeutic categories and is the largest exporter of pharmaceuticals in Bangladesh. The company has a growing global presence across five continents and is the only Bangladeshi pharmaceutical company marketing products in the US.
IMPREX provides marketing and communications services to the medical and pharmaceutical industries, including the creation of promotional materials such as brochures, posters, and patient education materials. Headed by Onkarjot Bhatia Bakhshi, who has a background in biochemistry and marketing experience in the pharmaceutical industry, IMPREX recognizes that the healthcare industry is shifting towards empowered consumers and the important role social media now plays in promotion.
1. WOJCIECH CHRUŚCIEL
Telephone: +48 501 163 827
E-mail: wtc@e.pl
Address: ul. Dzika 6/284, 00-172 Warszawa
Date of birth: 1962
“I hereby give consent for my personal data included in my offer to be processed for the purposes of recruitment, in accordance with the Personal Data Protection Act
dated 29.08.1997 (uniform text: Journal of Laws of the Republic of Poland 2002 No 101, item 926 with further amendments).” Page 1 / 4
SUMMARY:
Managing Director/President of the Board with experience in managing organisations
and business structures in the following sectors: pharmaceutical, insurance, logistics.
Expert understanding of the Polish healthcare system. Advisor and Manager for the
Ministry of Health of the Republic of Poland. Appointed by the Minister of Regional
Development for the period between 31.10.2008 and 31.10.2013.
Extensive knowledge and experience restructuring business processes (e.g.
Chemikals).
Effective in building and managing large teams.
Advanced knowledge of French and good knowledge of English
KEY SKILLS AND RESPONSIBILITIES:
BUSINESS MANAGEMENT: creating and implementing business development concepts, managing projects focused on
launching new branches/expanding structures, budget management, marketing activities, maintaining relationships with
business partners and conducting business negotiations, inventory management.
GOOD KNOWLEDGE OF THE MEDICAL/PHARMACEUTICAL SECTOR: medical doctor diploma, good knowledge of managing the
pharmaceutical sector, developing and implementing healthcare projects.
TEAM MANAGEMENT: building teams, recruiting and motivating employees, delegating tasks, performing employee
appraisals, developing training programmes, conducting special training courses for managers.
QUALIFICATIONS: completed a course for Supervisory Board Members - Warsaw, 2004, approved by the Ministry of Treasury.
WORK EXPERIENCE:
06.2013-04.2015 Restaurant Subway Zakopane
Franchisee
02.2009 – 03.2013 Chemikals Sp. z o.o. Braniewo, part of Kulczyk Investment S.A.
09.2012 – 03.2013 Board Advisor
02.2009 – 09.2012 President of the Board
Monitored the process of registering the company and making a contribution to the company’s assets.
Managed the company (140 employees).
Financial and organisational restructuring of the company.
High revenues in a time of crisis, EBITDA: +18%.
Purchased the Logistic Port Skandawa terminal – modernisation and restructuring.
2007 – 2008 PZU Życie S.A.
Health Insurance Department
Head of the Department/Project Sponsor
Managed an internal project focused on developing the company’s strategy for health insurance products.
Sponsor of a project focused on implementing new health insurance products (coverage for surgery) – the
project’s products were approved by the company’s board at 02.2008.
2. WOJCIECH CHRUŚCIEL
Telephone: +48 501 163 827
E-mail: wtc@e.pl
Address: ul. Dzika 6/284, 00-172 Warszawa
Date of birth: 1962
“I hereby give consent for my personal data included in my offer to be processed for the purposes of recruitment, in accordance with the Personal Data Protection Act
dated 29.08.1997 (uniform text: Journal of Laws of the Republic of Poland 2002 No 101, item 926 with further amendments).” Page 2 / 4
2006 – 2007 Ministry of Health of the Republic of Poland
10.2006-04.2007 Structural Funds and Aid Programmes Department
Director
Launched a new department.
Vice president of a team responsible for forecasting healthcare costs for the period between 2007 and 2015.
Actively participated in a team responsible for updating the Healthcare Development Strategy for the period
between 2007 and 2015.
01.2006-10.2006 Drug Policy Department
Coordinator of the Registration Section and the Organisation and Legal Section
Monitored the work of the Registration Section and the Organisation and Legal Section.
Developed „standards for use and financing of treatment applying off-label use of drugs”.
Worked on amendments to the Pharmaceutical Law Act.
Prepared several regulations.
Author of the concept of amendments to the list of reimbursed drugs.
1996 – 2005 C.M.S. Sp. z o.o. Warsaw
President of the Board
Launched and managed a network of pharmacies (Apteka Rodzinna): 6 pharmacies launched between 1999 and
12.2003.
Maximised the market value of the assets and the company – sold 5 pharmacies.
Developed marketing, operations, organisation and layout concepts for the network of pharmacies.
Prepared an Operations Manual for the network of pharmacies (1999-2001).
Developed and implemented a project: „POGOTOWIE APTEKARSKIE - dostawa leków do domu” (home delivery of
drugs), 2003-2004.
Prepared and conducted training courses for pharmacy managers (e.g. „Modern pharmacy management”).
1994 – 1996 DISFAPOL Sp. z o.o. Łódź/ Disfapol Krako Sp. z o.o., Kraków
/ pharmaceutical wholesale companies owned by the ORFE group/
President of the Board, General Director
1992 – 1994 CORMAY Poznań SP. z .o.o.
/pharmaceutical wholesale company/
President of the Board
1992 – 1994 CORMAY POLAND Sp. z o.o.
/ pharmaceutical wholesale company/
BoM Representative responsible for Branches
1991 – 1992 OCP Poland, Warsaw
/branch of OCP S.A./
3. WOJCIECH CHRUŚCIEL
Telephone: +48 501 163 827
E-mail: wtc@e.pl
Address: ul. Dzika 6/284, 00-172 Warszawa
Date of birth: 1962
“I hereby give consent for my personal data included in my offer to be processed for the purposes of recruitment, in accordance with the Personal Data Protection Act
dated 29.08.1997 (uniform text: Journal of Laws of the Republic of Poland 2002 No 101, item 926 with further amendments).” Page 3 / 4
Marketing Director
Developed and implemented a management accounting system.
Developed a logistics model for supplying pharmacies.
Conducted negotiations with suppliers.
1991 Office Commercial Pharmaceutique S.A., Paris, France
International Marketing Assistant
ADDITIONAL EXPERIENCE:
2001 – 2002 JELFA S.A. Jelenia Góra
Supervisory Board Member
1998 – 2000 CORMAY Poland S.A. Warsaw
BoM Representative responsible for Integrated Companies
– President of the Board at POLSKI DOM FARMACEUTYCZNY sp. z o. o. (Szczecin), Vice President of the
Board at EUROMED sp. z o. o. (Rzeszów), President of the Supervisory Board at CORDA sp. z o. o.
(Lublin), Supervisory Board Member at FARMACJA SZCZECIN S.A., HAFIS sp. z o. o. (Tychy).
1997 – 1998 Baby Collection, Warsaw
/wholesaler of products for infants and children, exclusive importer of Chicco products/
Managing Director
EDUCATION:
1990 – 1991 Ecole Supérieure de Commerce, Dijon (France) – business school
Mastere spécialisé: Management de l'Industrie Pharmaceutique/ Postgraduate MBA studies:
Management in the Pharmaceutical Industry
1980 – 1987 Medical University of Warsaw
Medical Doctor Diploma
SELECTED TRAINING COURSES:
Management: Commercial Companies Code and new legal regulations on limited companies, 2001; Study of
supervisory board members, senators, administrative receivers and members of contract management groups,
1993.
ADDITIONAL INFORMATION:
French language – fluent, spoken and written.
English language – good.
Computer skills: Windows OS, Word, Excel, PowerPoint.
Driving licence, category B (since 1978).
Author of articles for the pharmaceutical press.
4. WOJCIECH CHRUŚCIEL
Telephone: +48 501 163 827
E-mail: wtc@e.pl
Address: ul. Dzika 6/284, 00-172 Warszawa
Date of birth: 1962
“I hereby give consent for my personal data included in my offer to be processed for the purposes of recruitment, in accordance with the Personal Data Protection Act
dated 29.08.1997 (uniform text: Journal of Laws of the Republic of Poland 2002 No 101, item 926 with further amendments).” Page 4 / 4
INTERESTS:
Skiing, swimming, sailing, travel.
REFERENCES:
References available upon request.